Literature DB >> 9375976

Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.

S Schuller-Petrovic1, S Siedler, T Kern, J Meinhart, K Schmidt, F Brunner.   

Abstract

1. The role of the endothelium in the vasomotor control of human veins in the lower extremity is little understood. We tested the hypothesis that the production of relaxing and contracting factors is altered in endothelial cells from varicose saphenous veins which may predispose to the decreased vessel tone observed in primary varicosis. 2. We determined the intracellular accumulation of guanosine 3':5'-cyclic monophosphate cyclic GMP; a measure of nitric oxide production and the release of endothelin and prostacyclin (measured as its stable metabolite 6-keto-prostaglandin F1alpha) from cultured cells derived from the long saphenous veins of patients with primary varicosis (Varicose saphena group, n = 27) or from patients undergoing coronary artery bypass surgery (Healthy saphena group, n = 22). In addition, levels of endothelin, angiotensin II, bradykinin, cyclic GMP and cyclic AMP in plasma from patients with primary varicosis and healthy volunteers (n = 8-11 in each group) were determined. 3. Although basal cyclic GMP levels were similar, more cyclic GMP accumulated in response to histamine (1-100 micromol l[-1]) in cells from varicose saphenous veins (0.75 +/- 0.1 pmol per well) than in cells from veins without varicosis (0.27 +/- 0.05 pmol per well). Furthermore, the relaxant potency of nitroprusside (1 nmol l(-1) - 300 micromol l[-1]) in vitro was higher for varicose veins (mean EC50 = 5.9 micromol l(-1); n = 8) than healthy veins (mean EC50 = 20.0 micromol l(-1); n = 7). 4. The production of prostacyclin was significantly less in cells from varicose than healthy saphenous veins (66 +/- 8.7 and 121 +/- 20.1 nmol g(-1) protein), but the production of endothelin was similar in both groups. Prostacyclin (3 nmol l(-1) 30 micromol l[-1]) consistently contracted rings of varicose saphenous vein in vitro with a mean EC50 value of 10-20 micromol l(-1) (n = 7); the maximum tension generated was approximately 50% of that of a completely depolarizing solution of K+ (120 mmol l[-1]). 5. In plasma from patients with varicose veins, levels of cyclic GMP were higher than in healthy controls (9.2 +/- 0.03 and 7.2 +/- 0.02 nmol l[-1]), levels of angiotensin II were lower (81 +/- 11.5 and 147 +/- 21.7 pmol l[-1]), and levels of endothelin, cyclic AMP, and bradykinin were not different. 6. It is concluded that endothelial cells from diseased saphenous veins secrete less constrictor mediators than cells from healthy veins and that in diseased veins the nitric oxide/cyclic GMP system is up-regulated which may shift the balance of vasoactive factors towards vasodilatation and contribute to the development of primary varicosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375976      PMCID: PMC1564992          DOI: 10.1038/sj.bjp.0701437

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

2.  Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Katie G Beauregard; Alain F Tanbe; Abhinav Kumar; Virak Mam; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

3.  Responsiveness of human varicose saphenous veins to vasoactive agents.

Authors:  F Brunner; C Hoffmann; S Schuller-Petrovic
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

4.  Sympathetic and cardiovascular responses to glossopharyngeal insufflation in trained apnea divers.

Authors:  Karsten Heusser; Gordan Dzamonja; Toni Breskovic; Craig D Steinback; André Diedrich; Jens Tank; Jens Jordan; Zeljko Dujic
Journal:  J Appl Physiol (1985)       Date:  2010-09-23

5.  Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

6.  Increased vasoconstrictor reactivity and decreased endothelial function in high grade varicocele; functional and morphological study.

Authors:  Oguzhan Yildiz; Husamettin Gul; Yaşar Ozgok; Onder Onguru; Mete Kilciler; Ahmet Aydin; Askin Isimer; A Cetin Harmankaya
Journal:  Urol Res       Date:  2003-07-11

Review 7.  Immunological aspects of chronic venous disease pathogenesis.

Authors:  Ewa Grudzińska; Zenon Paweł Czuba
Journal:  Cent Eur J Immunol       Date:  2014-12-15       Impact factor: 2.085

8.  In vivo and in vitro assessment of human saphenous vein wall changes.

Authors:  Akram M Asbeutah; Sami K Asfar; Hussain Safar; Mabayoje A Oriowo; Ihab Elhagrassi; Mona A Abu-Assi; James D Cameron; Barry P McGrath
Journal:  Open Cardiovasc Med J       Date:  2007-08-17

9.  Tissue remodeling investigation in varicose veins.

Authors:  Sayyed Mohammad Hossein Ghaderian; Zohreh Khodaii
Journal:  Int J Mol Cell Med       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.